Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,722 | 108 | 61.0% |
| Gift | $1,215 | 3 | 19.9% |
| Travel and Lodging | $848.63 | 5 | 13.9% |
| Education | $317.54 | 5 | 5.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| NxThera, Inc. | $1,651 | 12 | $0 (2017) |
| Medtronic USA, Inc. | $976.38 | 8 | $0 (2018) |
| Astellas Pharma US Inc | $818.53 | 24 | $0 (2024) |
| PROCEPT BioRobotics Corporation | $658.72 | 7 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $432.03 | 11 | $0 (2023) |
| Valeant Pharmaceuticals North America LLC | $209.27 | 4 | $0 (2017) |
| Boston Scientific Corporation | $155.03 | 5 | $0 (2023) |
| Allergan, Inc. | $154.82 | 3 | $0 (2020) |
| Dendreon Pharmaceuticals LLC | $154.52 | 3 | $0 (2018) |
| Medtronic, Inc. | $128.18 | 7 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $319.37 | 6 | PROCEPT BioRobotics Corporation ($232.31) |
| 2023 | $594.03 | 12 | PROCEPT BioRobotics Corporation ($426.41) |
| 2022 | $83.02 | 5 | Medtronic, Inc. ($28.82) |
| 2021 | $307.69 | 14 | Medtronic, Inc. ($83.25) |
| 2020 | $256.95 | 5 | Astellas Pharma US Inc ($211.42) |
| 2019 | $135.37 | 2 | Abbott Laboratories ($115.00) |
| 2018 | $1,228 | 16 | Medtronic USA, Inc. ($976.38) |
| 2017 | $3,180 | 61 | NxThera, Inc. ($1,651) |
All Payment Transactions
121 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/14/2024 | Calyxo, Inc. | CVAC ASPIRATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $24.38 | General |
| Category: Urology | ||||||
| 05/03/2024 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $43.29 | General |
| 04/10/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $158.82 | General |
| Category: UROLOGY | ||||||
| 03/27/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: UROLOGY | ||||||
| 02/27/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $34.24 | General |
| Category: UROLOGY | ||||||
| 02/09/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $39.25 | General |
| Category: UROLOGY | ||||||
| 12/15/2023 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 12/01/2023 | Endo Pharmaceuticals Inc. | AVEED (Biological), XIAFLEX | Food and Beverage | In-kind items and services | $23.87 | General |
| Category: UROLOGY | ||||||
| 09/30/2023 | Supernus Pharmaceuticals, Inc. | XYOSTED (Drug), TLANDO | Food and Beverage | In-kind items and services | $24.10 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 09/14/2023 | Boston Scientific Corporation | AMS 700 (Device) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: AMS 700_URO | ||||||
| 09/09/2023 | Endo Pharmaceuticals Inc. | AVEED (Biological), XIAFLEX | Food and Beverage | In-kind items and services | $23.37 | General |
| Category: UROLOGY | ||||||
| 09/07/2023 | PROCEPT BioRobotics Corporation | AQUABEAM ROBOTIC SYSTEM (Device) | Food and Beverage | In-kind items and services | $71.03 | General |
| Category: Urology | ||||||
| 08/23/2023 | PROCEPT BioRobotics Corporation | AQUABEAM ROBOTIC SYSTEM (Device) | Food and Beverage | In-kind items and services | $151.39 | General |
| Category: Urology | ||||||
| 06/27/2023 | Boston Scientific Corporation | AMS 700 (Device) | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: AMS 700_URO | ||||||
| 04/21/2023 | PROCEPT BioRobotics Corporation | AQUABEAM ROBOTIC SYSTEM (Device) | Food and Beverage | In-kind items and services | $42.37 | General |
| Category: Urology | ||||||
| 04/10/2023 | Endo Pharmaceuticals Inc. | AVEED (Biological), XIAFLEX | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: UROLOGY | ||||||
| 03/28/2023 | PROCEPT BioRobotics Corporation | AQUABEAM ROBOTIC SYSTEM (Device) | Food and Beverage | In-kind items and services | $161.62 | General |
| Category: Urology | ||||||
| 02/04/2023 | Endo Pharmaceuticals Inc. | AVEED (Biological), XIAFLEX | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: UROLOGY | ||||||
| 10/12/2022 | Endo Pharmaceuticals Inc. | XIAFLEX (Biological), AVEED, EDEX | Food and Beverage | In-kind items and services | $24.85 | General |
| Category: UROLOGY | ||||||
| 04/28/2022 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 03/14/2022 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $11.85 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 02/08/2022 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: Oncology | ||||||
| 01/18/2022 | ABC Home Medical Supply, Inc. | — | Food and Beverage | In-kind items and services | $11.84 | General |
| 11/16/2021 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: ONCOLOGY | ||||||
| 11/02/2021 | COLOPLAST CORP | SpeediCath (Device) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: Continence Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 899 | 1,083 | $447,672 | $128,071 |
| 2022 | 7 | 403 | 468 | $133,799 | $44,725 |
| 2021 | 7 | 305 | 370 | $82,589 | $31,392 |
| 2020 | 7 | 263 | 354 | $151,828 | $25,728 |
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 216 | 310 | $93,310 | $32,203 | 34.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 220 | 220 | $101,420 | $28,082 | 27.7% |
| 53854 | Destruction of prostate tissue using radiofrequency induced heated water vapor | Office | 2023 | 16 | 16 | $104,064 | $24,830 | 23.9% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 66 | 70 | $45,850 | $15,018 | 32.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 111 | 133 | $27,132 | $9,057 | 33.4% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 20 | 22 | $31,602 | $7,817 | 24.7% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Office | 2023 | 12 | 12 | $11,052 | $3,431 | 31.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 20 | 28 | $4,396 | $1,856 | 42.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 15 | 17 | $5,032 | $1,850 | 36.8% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 143 | 187 | $13,838 | $1,741 | 12.6% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 17 | 21 | $1,881 | $668.15 | 35.5% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 13 | 13 | $3,601 | $574.51 | 16.0% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 13 | 13 | $3,318 | $513.86 | 15.5% |
| 74420 | Imaging of urinary tract following injection of a contrast agent | Facility | 2023 | 17 | 21 | $1,176 | $430.08 | 36.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 85 | 85 | $38,005 | $11,686 | 30.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 92 | 105 | $30,180 | $10,855 | 36.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 83 | 106 | $21,000 | $8,088 | 38.5% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 36 | 37 | $23,120 | $7,909 | 34.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 39 | 39 | $11,817 | $3,709 | 31.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 15 | 31 | $4,867 | $1,852 | 38.1% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2022 | 53 | 65 | $4,810 | $625.88 | 13.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 72 | 93 | $22,338 | $9,512 | 42.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 82 | 112 | $17,535 | $7,839 | 44.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 54 | 54 | $18,872 | $6,702 | 35.5% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Office | 2021 | 32 | 33 | $20,959 | $6,578 | 31.4% |
About Dr. Mrinal Dhar, MD
Dr. Mrinal Dhar, MD is a Urology healthcare provider based in Eastvale, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/04/2010. The National Provider Identifier (NPI) number assigned to this provider is 1417275256.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mrinal Dhar, MD has received a total of $6,104 in payments from pharmaceutical and medical device companies, with $319.37 received in 2024. These payments were reported across 121 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($3,722).
As a Medicare-enrolled provider, Dhar has provided services to 1,870 Medicare beneficiaries, totaling 2,275 services with total Medicare billing of $229,917. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Eastvale, CA
- Active Since 05/04/2010
- Last Updated 11/01/2018
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1417275256
Products in Payments
- Rezum (Device) $1,651
- INTERSTIM (Device) $1,105
- AQUABEAM ROBOTIC SYSTEM (Device) $426.41
- PROVENGE (Drug) $363.79
- XIAFLEX (Biological) $340.78
- Myrbetriq (Drug) $297.07
- AQUABEAM SYSTEM (Device) $232.31
- XTANDI (Drug) $148.20
- BOTOX OAB (Drug) $124.01
- Mitra Clip system (Device) $115.00
- Androgel (Drug) $110.86
- Xtandi (Drug) $100.86
- ELIGARD (Drug) $91.94
- AVEED (Biological) $91.25
- ADVANTAGE FIT SYSTEM (Device) $86.25
- Noctiva (Drug) $60.00
- ORGOVYX (Drug) $50.24
- GEMTESA (Drug) $42.39
- XYOSTED (Drug) $41.48
- Onli (Device) $39.30
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.